(firstQuint)Gefitinib Combined With Radiotherapy in Elderly Patients With Esophageal Cancer.

 Purpose: to evaluate the efficacy and toxicity of a concomitant treatment using EGFR-TKI and thoracic radiation in elderly patients with esophageal Cancer.

 Methods:Patients(>70 years old) with esophageal Cancer will receive thoracic radiation therapy 54-60 Gy over 30 fractions and concurrent with gefitinib 250mg/day.

.

 Gefitinib Combined With Radiotherapy in Elderly Patients With Esophageal Cancer@highlight

Elderly patients with esophageal cancer will receive thoracic radiation therapy 54-60Gy over 30 fractions, and concurrent with Gefitinib.

